{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:31:25Z","timestamp":1792704685584,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ophtha.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T08:00:46Z","timestamp":1397635246000},"page":"1495-1500.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Association between In Vitro Susceptibility to Natamycin and Voriconazole and Clinical Outcomes in Fungal Keratitis"],"prefix":"10.1016","volume":"121","clinical-trial-number":[{"clinical-trial-number":"nct00996736","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Catherine Q.","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajna","family":"Lalitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Venkatesh","family":"Prajna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajarathinam","family":"Karpagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoharan","family":"Geetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran S.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.03.004_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/bjo.81.8.622","article-title":"Corneal ulceration in the developing world\u2014a silent epidemic","volume":"81","author":"Whitcher","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00003226-200005000-00010","article-title":"Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania","volume":"19","author":"Tanure","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.004_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0161-6420(94)31225-5","article-title":"The changing spectrum of fungal keratitis in south Florida","volume":"101","author":"Rosa","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.004_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.ico.0000177423.77648.8d","article-title":"Fungal keratitis at the New York Eye and Ear Infirmary","volume":"25","author":"Ritterband","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.004_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00003226-200208000-00004","article-title":"The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India","volume":"21","author":"Gopinathan","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.004_bib6","first-page":"315","article-title":"Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study","volume":"51","author":"Bharathi","year":"2003","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00055735-200408000-00008","article-title":"Fungal keratitis","volume":"15","author":"Srinivasan","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/342384","article-title":"Has antifungal susceptibility testing come of age?","volume":"35","author":"Rex","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2014.03.004_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/clinids\/5.1.54","article-title":"The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis","volume":"5","author":"Weinstein","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ophtha.2014.03.004_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bjo.2009.158675","article-title":"Susceptibility testing and clinical outcome in fungal keratitis [letter]","volume":"94","author":"Shapiro","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/ICO.0b013e31823f8ae0","article-title":"Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial","volume":"31","author":"Lalitha","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.004_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jac\/42.4.497","article-title":"In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis","volume":"42","author":"Lass-Florl","year":"1998","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"suppl","key":"10.1016\/j.ophtha.2014.03.004_bib13","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0924-8579(08)70010-4","article-title":"Clinical relevance of resistance to antifungals","volume":"32","author":"Rodriguez-Tudela","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ophtha.2014.03.004_bib14","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajo.2003.11.078","article-title":"In\u00a0vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens","volume":"137","author":"Marangon","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archopht.125.6.789","article-title":"Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis","volume":"125","author":"Lalitha","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"Mycotic Ulcer Treatment Trial Group. The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib17","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard","author":"Rex","year":"2008"},{"key":"10.1016\/j.ophtha.2014.03.004_bib18","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2014.03.004_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/CMR.14.4.643-658.2001","article-title":"Antifungal susceptibility testing: practical aspects and current challenges","volume":"14","author":"Rex","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ophtha.2014.03.004_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00003226-198706040-00002","article-title":"Selection of appropriate antifungal therapy","volume":"6","author":"O'Day","year":"1987","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.004_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.00762-06","article-title":"Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis","volume":"51","author":"Thiel","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ophtha.2014.03.004_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archophthalmol.2007.71","article-title":"Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study","volume":"126","author":"Lau","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archophthalmol.2007.8","article-title":"Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans","volume":"126","author":"Vemulakonda","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.004_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2013.10.004","article-title":"In\u00a0vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial","volume":"157","author":"Lalitha","year":"2014","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:05:05Z","timestamp":1758981905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0161642014002024"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718356738.793499167","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between In Vitro Susceptibility to Natamycin and Voriconazole and Clinical Outcomes in Fungal Keratitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}